A detailed history of Mendel Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mendel Capital Management LLC holds 7,213 shares of ABBV stock, worth $1.29 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
7,213
Previous 6,997 3.09%
Holding current value
$1.29 Million
Previous $1.2 Million 18.67%
% of portfolio
0.88%
Previous 0.78%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $35,389 - $43,055
216 Added 3.09%
7,213 $1.42 Million
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $10,990 - $12,833
71 Added 1.03%
6,997 $1.2 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $144,637 - $164,800
905 Added 15.03%
6,926 $1.26 Million
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $34,950 - $39,362
254 Added 4.4%
6,021 $933,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $18,569 - $21,496
139 Added 2.47%
5,767 $859,000
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $10,733 - $13,356
81 Added 1.46%
5,628 $758,000
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $121,906 - $140,393
843 Added 17.92%
5,547 $884,000
Q4 2022

Jan 23, 2023

BUY
$138.31 - $165.87 $30,981 - $37,154
224 Added 5.0%
4,704 $0
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $73,547 - $84,353
548 Added 13.94%
4,480 $601,000
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $26,285 - $33,417
-191 Reduced 4.63%
3,932 $602,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $4,223 - $5,240
32 Added 0.78%
4,123 $668,000
Q4 2021

Feb 16, 2022

BUY
$107.43 - $135.93 $439,496 - $556,089
4,091 New
4,091 $554,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mendel Capital Management LLC Portfolio

Follow Mendel Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Capital Management LLC with notifications on news.